Drug Profile
BSN 001
Alternative Names: BSN-001Latest Information Update: 28 Jun 2020
Price :
$50
*
At a glance
- Originator Boryung Pharmaceutical
- Class Small molecules
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus; Hypertension
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Diabetes-mellitus in South Korea (PO)
- 28 Jun 2020 No recent reports of development identified for research development in Hypertension in South Korea (PO)
- 06 May 2016 Early research in Diabetes mellitus in South Korea (unspecified route)